The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine
Clinical trial NCT05213143 · TERMINATED
Trial details
- NCT number
- NCT05213143
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2022-11-18
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.